Cargando…
All-cause and cause-specific mortality associated with diabetes in prevalent hemodialysis patients
BACKGROUND: Diabetes is the most common risk factor for end-stage renal disease (ESRD) and has been associated with increased risk of death. In order to better understand the influence of diabetes on outcomes in hemodialysis, we examine the risk of death of diabetic participants in the HEMODIALYSIS...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3519533/ https://www.ncbi.nlm.nih.gov/pubmed/23025844 http://dx.doi.org/10.1186/1471-2369-13-130 |
_version_ | 1782252681478275072 |
---|---|
author | Sattar, Abdus Argyropoulos, Christos Weissfeld, Lisa Younas, Nizar Fried, Linda Kellum, John A Unruh, Mark |
author_facet | Sattar, Abdus Argyropoulos, Christos Weissfeld, Lisa Younas, Nizar Fried, Linda Kellum, John A Unruh, Mark |
author_sort | Sattar, Abdus |
collection | PubMed |
description | BACKGROUND: Diabetes is the most common risk factor for end-stage renal disease (ESRD) and has been associated with increased risk of death. In order to better understand the influence of diabetes on outcomes in hemodialysis, we examine the risk of death of diabetic participants in the HEMODIALYSIS (HEMO) study. METHODS: In the HEMO study, 823 (44.6%) participants were classified as diabetic. Using the Schoenfeld residual test, we found that diabetes violated the proportional hazards assumption. Based on this result, we fit two non-proportional hazard models: Cox’s time varying covariate model (Cox-TVC) that allows the hazard for diabetes to change linearly with time and Gray’s time-varying coefficient model. RESULTS: Using the Cox-TVC, the hazard ratio (HR) for diabetes increased with each year of follow up (p = 0.02) for all cause mortality. Using Gray’s model, the HR for diabetes ranged from 1.41 to 2.21 (p <0.01). The HR for diabetes using Gray’s model exhibited a different pattern, being relatively stable at 1.5 for the first 3 years in the study and increasing afterwards. CONCLUSION: Risk of death associated with diabetes in ESRD increases over time and suggests that an increasing risk of death among diabetes may be underappreciated when using conventional survival models. |
format | Online Article Text |
id | pubmed-3519533 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-35195332012-12-12 All-cause and cause-specific mortality associated with diabetes in prevalent hemodialysis patients Sattar, Abdus Argyropoulos, Christos Weissfeld, Lisa Younas, Nizar Fried, Linda Kellum, John A Unruh, Mark BMC Nephrol Research Article BACKGROUND: Diabetes is the most common risk factor for end-stage renal disease (ESRD) and has been associated with increased risk of death. In order to better understand the influence of diabetes on outcomes in hemodialysis, we examine the risk of death of diabetic participants in the HEMODIALYSIS (HEMO) study. METHODS: In the HEMO study, 823 (44.6%) participants were classified as diabetic. Using the Schoenfeld residual test, we found that diabetes violated the proportional hazards assumption. Based on this result, we fit two non-proportional hazard models: Cox’s time varying covariate model (Cox-TVC) that allows the hazard for diabetes to change linearly with time and Gray’s time-varying coefficient model. RESULTS: Using the Cox-TVC, the hazard ratio (HR) for diabetes increased with each year of follow up (p = 0.02) for all cause mortality. Using Gray’s model, the HR for diabetes ranged from 1.41 to 2.21 (p <0.01). The HR for diabetes using Gray’s model exhibited a different pattern, being relatively stable at 1.5 for the first 3 years in the study and increasing afterwards. CONCLUSION: Risk of death associated with diabetes in ESRD increases over time and suggests that an increasing risk of death among diabetes may be underappreciated when using conventional survival models. BioMed Central 2012-10-01 /pmc/articles/PMC3519533/ /pubmed/23025844 http://dx.doi.org/10.1186/1471-2369-13-130 Text en Copyright ©2012 Sattar et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Sattar, Abdus Argyropoulos, Christos Weissfeld, Lisa Younas, Nizar Fried, Linda Kellum, John A Unruh, Mark All-cause and cause-specific mortality associated with diabetes in prevalent hemodialysis patients |
title | All-cause and cause-specific mortality associated with diabetes in prevalent hemodialysis patients |
title_full | All-cause and cause-specific mortality associated with diabetes in prevalent hemodialysis patients |
title_fullStr | All-cause and cause-specific mortality associated with diabetes in prevalent hemodialysis patients |
title_full_unstemmed | All-cause and cause-specific mortality associated with diabetes in prevalent hemodialysis patients |
title_short | All-cause and cause-specific mortality associated with diabetes in prevalent hemodialysis patients |
title_sort | all-cause and cause-specific mortality associated with diabetes in prevalent hemodialysis patients |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3519533/ https://www.ncbi.nlm.nih.gov/pubmed/23025844 http://dx.doi.org/10.1186/1471-2369-13-130 |
work_keys_str_mv | AT sattarabdus allcauseandcausespecificmortalityassociatedwithdiabetesinprevalenthemodialysispatients AT argyropouloschristos allcauseandcausespecificmortalityassociatedwithdiabetesinprevalenthemodialysispatients AT weissfeldlisa allcauseandcausespecificmortalityassociatedwithdiabetesinprevalenthemodialysispatients AT younasnizar allcauseandcausespecificmortalityassociatedwithdiabetesinprevalenthemodialysispatients AT friedlinda allcauseandcausespecificmortalityassociatedwithdiabetesinprevalenthemodialysispatients AT kellumjohna allcauseandcausespecificmortalityassociatedwithdiabetesinprevalenthemodialysispatients AT unruhmark allcauseandcausespecificmortalityassociatedwithdiabetesinprevalenthemodialysispatients |